🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 4525EP101 (prev. 92847R104 )
- Market Cap
- Micro Cap
- IPO
- 4/17/2014 · $12.00/share
- Previous Symbol
- VTL (changed 4/12/2019)
- Previous Name
- Vital Therapies, Inc.
Business: Immunic, Inc.. is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
Notes: April 12, 2019 -- Vital Therapies, Inc. completed its previously announced stock-for-stock transaction with Immunic AG, Germany. In connection with the closing of the transaction, Vital Therapies has changed its name to Immunic, Inc. and the Company’s shares now trade on The Nasdaq Stock Market under the symbol IMUX.
Company Contact
- CEO
- Daniel Vitt
- CFO
- Glenn Whaley
- Headquarters
- 1200 Avenue of the Americas , Suite 200 , New York, NY 10036
- Phone
- 332-255-9818
- Fax
- 858-673-6843
- Investor Relations
- Paula Schwartz , Rx Communications · 917-322-2216 · immunic@rxir.com